Miika Leppänen

Mr. Miika Leppänen

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
GVGurinder Vinner
Gurinder Vinner
KRKerry Richards
Kerry Richards
MLMiika Leppänen
Miika Leppänen
Antonia SagonaAntonia Sagona
Antonia Sagona
DMDanish Malik
Danish Malik
A scalable low-shear membrane emulsification process was used to produce microencapsulated Escherichia coli-phages in a solid oral dosage form. Uniform pH-responsive composite microparticles (mean size ~100 µm) composed of Eudragit® S100 and alginate were produced. The internal microstructure of the gelled microcapsules was studied using ion-milling and imaging, which showed that the microparticles had a solid internal core. The microencapsulation process significantly protected phages upon prolonged exposure to a simulated gastric acidic environment. Encapsulated phages that had been pre-exposed to simulated gastric acid were added to actively growing bacterial cells using in vitro cell cultures and were found to be effective in killing E. coli. Encapsulated phages were also shown to be effective in killing actively growing E. coli in the presence of human epithelial cells. Confocal microscopy images showed that the morphology of encapsulated phage-treated epithelial cells was considerably better than controls without phage treatment. The encapsulated phages were stable during refrigerated storage over a four-week period. The process of membrane emulsification is highly scalable and is a promising route to produce industrial quantities of pH-responsive oral solid dosage forms suitable for delivering high titres of viable phages to the gastrointestinal tract.

22 March 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
GVGurinder Vinner
Gurinder Vinner
ZRZahra Rezaie-Yazdi
Zahra Rezaie-Yazdi
MLMiika Leppänen
Miika Leppänen
ASAndrew G.F. Stapley
Andrew G.F. Stapley
Mark LeaperMark Leaper
Mark Leaper
DMDanish Malik
Danish Malik
The treatment of enteric bacterial infections using oral bacteriophage therapy can be challenging since the harsh acidic stomach environment renders phages inactive during transit through the gastrointestinal tract. Solid oral dosage forms allowing site-specific gastrointestinal delivery of high doses of phages, e.g., using a pH or enzymatic trigger, would be a game changer for the nascent industry trying to demonstrate the efficacy of phages, including engineered phages for gut microbiome modulation in expensive clinical trials. Spray-drying is a scalable, low-cost process for producing pharmaceutical agents in dry powder form. Encapsulation of a model Salmonella-specific phage (Myoviridae phage Felix O1) was carried out using the process of spray-drying, employing a commercially available Eudragit S100® pH-responsive anionic copolymer composed of methyl methacrylate-co-methacrylic acid formulated with trehalose. Formulation and processing conditions were optimised to improve the survival of phages during spray-drying, and their subsequent protection upon exposure to simulated gastric acidity was demonstrated. Addition of trehalose to the formulation was shown to protect phages from elevated temperatures and desiccation encountered during spray-drying. Direct compression of spray-dried encapsulated phages into tablets was shown to significantly improve phage protection upon exposure to simulated gastric fluid. The results reported here demonstrate the significant potential of spray-dried pH-responsive formulations for oral delivery of bacteriophages targeting gastrointestinal applications.

3 July 2017 in Advanced Biosystems
Verified
Journal Article
Closed access
PDF file
MLMiika Leppänen
Miika Leppänen
LSLotta‐Riina Sundberg
Lotta‐Riina Sundberg
ELElina Laanto
Elina Laanto
GAGabriel Magno de Freitas Almeida
Gabriel Magno de Freitas Almeida
PPPetri Papponen
Petri Papponen
IMIlari Maasilta
Ilari Maasilta

9 June 2020 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
CBChaturanga D. Bandara
Chaturanga D. Bandara
GBGiulia Ballerin
Giulia Ballerin
MLMiika Leppänen
Miika Leppänen
TTTuquabo Tesfamichael
Tuquabo Tesfamichael
Kostya (Ken) OstrikovKostya (Ken) Ostrikov
Kostya (Ken) Ostrikov
CWCynthia B. Whitchurch
Cynthia B. Whitchurch

1 November 2018 in Research in Microbiology
Verified
Journal Article
Closed access
Gabriel Magno de Freitas AlmeidaGabriel Magno de Freitas Almeida
Gabriel Magno de Freitas Almeida
MLMiika Leppänen
Miika Leppänen
IMIlari J. Maasilta
Ilari J. Maasilta
LSLotta-Riina Sundberg
Lotta-Riina Sundberg

20 May 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
AKAnnika E. Ketola
Annika E. Ketola
MLMiika Leppänen
Miika Leppänen
TTTuomas Turpeinen
Tuomas Turpeinen
PPPetri Papponen
Petri Papponen
ASAnders Strand
Anders Strand
ERElias Retulainen
Elias Retulainen
TEMPO-oxidized cellulose nanofibrils (TCNFs) have unique properties, which can be utilised in many application fields from printed electronics to packaging. Visual characterisation of TCNFs has been commonly performed using Scanning Electron Microscopy (SEM). However, a novel imaging technique, Helium Ion Microscopy (HIM), offers benefits over SEM, including higher resolution and the possibility of imaging non-conductive samples uncoated. HIM has not been widely utilized so far, and in this study the capability of HIM for imaging of TCNFs was evaluated. Freeze drying and critical point drying (CPD) techniques were applied to preserve the open fibril structure of the gel-like TCNFs. Both drying methods worked well, but CPD performed better resulting in the specific surface area of 386 m2 g−1 when compared to 172 m2 g−1 and 42 m2 g−1 of freeze dried samples frozen in propane and nitrogen, respectively. HIM imaging of TCNFs was successful but high magnification imaging was challenging because the ion beam tended to degrade the TCNFs. The effect of the imaging parameters on the degradation was studied and an ion dose as low as 0.9 ion per nm2 was required to prevent the damage. This study points out the differences between the gentle drying methods of TCNFs and demonstrates beam damage during imaging like none previously reported with HIM. The results can be utilized in future studies of cellulose or other biological materials as there is a growing interest for both the HIM technique and bio-based materials.